- Home
- IOVA vs SBSI Comparison
IOVA vs SBSI Comparison
Compare IOVA & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IOVA | SBSI |
|---|---|---|
| Founded | 2007 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 920.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IOVA | SBSI |
|---|---|---|
| Price | $2.39 | $31.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 3 |
| Target Price | $10.45 | ★ $33.50 |
| AVG Volume (30 Days) | ★ 12.6M | 111.4K |
| Earning Date | 02-26-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.30 |
| Revenue | ★ $250,425,000.00 | $236,346,000.00 |
| Revenue This Year | $60.71 | $11.41 |
| Revenue Next Year | $59.52 | $5.33 |
| P/E Ratio | ★ N/A | $13.58 |
| Revenue Growth | ★ 175.62 | N/A |
| 52 Week Low | $1.64 | $25.85 |
| 52 Week High | $6.50 | $33.14 |
Technical Indicators
Market Signals| Indicator | IOVA | SBSI |
|---|---|---|
| Relative Strength Index (RSI) | 45.56 | 58.28 |
| Support Level | $2.29 | $31.11 |
| Resistance Level | $2.80 | $31.91 |
| Average True Range (ATR) | 0.18 | 0.55 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 13.57 | 84.86 |
Price Performance
Historical ComparisonAbout IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.